Search filters

List of works by Teele Kuusk

A Phase II, single-arm trial of neoadjuvant axitinib plus avelumab in patients with localized renal cell carcinoma who are at high risk of relapse after nephrectomy (NEOAVAX)

scientific article published on 26 April 2019

An analysis of SPECT/CT non-visualization of sentinel lymph nodes in renal tumors

scientific article published on 03 December 2018

Antiangiogenic therapy combined with immune checkpoint blockade in renal cancer

scientific article published on 11 April 2017

Cytoreductive nephrectomy in the current treatment algorithm

scientific article published on 27 September 2019

Cytoreductive nephrectomy: does CARMENA (Cancer du Rein Metastatique Nephrectomie et Antiangioge [Combining Acute Accent]niques) change everything?

scientific article published on 12 November 2019

Cytoreductive nephrectomy: does CARMENA (Cancer du Rein Metastatique Nephrectomie et Antiangiogéniques) change everything?

Deferred Cytoreductive Nephrectomy Following Presurgical Vascular Endothelial Growth Factor Receptor-targeted Therapy in Patients with Primary Metastatic Clear Cell Renal Cell Carcinoma: A Pooled Analysis of Prospective Trial Data

scientific article published on 16 January 2020

European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update

scientific article published on 23 February 2019

External beam radiation for the treatment of castration-resistant prostate cancer following primary hormonal therapy with androgen ablation: Analysis and outcome of 21 patients.

scientific article published on 6 February 2017

Follow-up after curative treatment of localised renal cell carcinoma

scientific article published on 16 May 2018

Limitations of Available Studies Prevent Reliable Comparison Between Tumour Ablation and Partial Nephrectomy for Patients with Localised Renal Masses: A Systematic Review from the European Association of Urology Renal Cell Cancer Guideline Panel

scientific article published on 31 March 2020

Long-term Survival After Resection of Sentinel Node Metastatic Renal Cell Carcinoma

scientific article published on 14 February 2017

Lymphatic drainage from renal tumors in vivo: a prospective sentinel node study using SPECT/CT imaging

scientific article published on 6 December 2017

Management of Sporadic Renal Angiomyolipomas: A Systematic Review of Available Evidence to Guide Recommendations from the European Association of Urology Renal Cell Carcinoma Guidelines Panel

scientific article published on 04 June 2019

Observation after Cytoreductive Nephrectomy in Patients with Synchronous Not Completely Resected Metastases of Renal Cell Carcinoma

scientific article published on 02 August 2017

Outcome of sentinel lymph node biopsy in patients with clinically non-metastatic renal cell carcinoma

scientific article published on 01 October 2018

Re: Adjuvant Chemotherapy in Upper Tract Urothelial Carcinoma (the POUT Trial): A Phase 3, Open-label, Randomised Controlled Trial

scientific article published on 22 May 2020

Re: Detection of Micrometastases by Flow Cytometry in Sentinel Lymph Nodes from Patients with Renal Tumours

scientific article published on 17 January 2017

Robotic-Assisted Laparoscopic Partial Nephrectomy in a Horseshoe Kidney. a Case Report and Review of the Literature

scientific article

Sentinel Lymph Node Biopsy in Renal Tumors: Surgical Technique and Safety

scientific article published on 30 April 2019

The Impact of Adding Sentinel Node Biopsy to Extended Pelvic Lymph Node Dissection on Biochemical Recurrence in Prostate Cancer Patients Treated with Robot-Assisted Radical Prostatectomy

scientific article published on 26 July 2017

The current management of renal cell carcinoma

scientific article

Topographic distribution of first landing sites of lymphatic metastases from patients with renal cancer

scientific article published on 02 March 2020

Treatment of renal angiomyolipoma: pooled analysis of individual patient data

scientific article

Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Immune Checkpoint Inhibition Is the New Backbone in First-line Treatment of Metastatic Clear-cell Renal Cell Carcinoma

scientific article published on 01 August 2019

Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Nivolumab plus Cabozantinib Joins Immune Checkpoint Inhibition Combination Therapies for Treatment-naïve Metastatic Clear-Cell Renal Cell Carcinoma

scientific article published on 20 December 2020